Neurolixis is pleased to announce a PhD Studentship Opportunity in collaboration with the University of Hertforshire (UK). The successful candidate will investigate the therapeutic potential of novel compounds (notably NLX-112) developed by Neurolixis. These compounds target serotonergic mechanisms which are involved in the neurobiology of Parkinson's disease and of neuroprotective functions. The project will provide training in a range of in vitro and in vivo techniques relevant to modern neuropharmacology including animal behavioral paradigms, neural circuitry relevant to Parkinson's disease and modern biochemical techniques.

The four-year project will start in early 2019 and includes a stipend of £14,777 per annum plus approved expenses.
For more information, or to submit an application, see the University of Hertforshire announcement here.

Newsletter

Please enable the javascript to submit this form

Follow Neurolixis on: